High-visibility packaging demand on the rise

The Freedonia Group forecasts that sales demand for high-visibility packaging in the pharmaceutical and medical markets will advance 7.9% annually to $1.9 billion by 2010. The organization refers to high-visibility packaging as packaging that allows consumers to see the product through the packaging. These include windowed boxes and bags, carded blister packs, skin packaging, and interlocking containers.

Apr 16, 2007

CPG Innovator: Supradeep Vankayala of Becton Dickinson

Vankayala is the lead design engineer, R&D at BD and responsible for developing a PFAS-free package solution. He reflects on his journey, the future of AI, and what’s driving packaging decisions in healthcare.

Talcid antacid medication blister pack and product box with rainbow gradient design

Bayer Launches Mono-Material PP Blister in Germany for Its Talcid Antacid Treatment

Five men posing together against dark curtain backdrop in black and white photograph

The Industry Comes Together at PACK EXPO International 2026

Three-stage skincare delivery system showing particles opening temporary pathways, melting into skin, and transforming into active ingredients.

Microneedle Challenges in Moving From R&D Into GMP-Ready Pharmaceutical Manufacturing

Lilly Breaks Ground on $6.5 Billion Houston Plant for Oral GLP-1 Foundayo

See What’s Possible in Life Sciences Packaging at PACK EXPO International

Explore new machinery & materials from 2,700 exhibitors. Gain insights from 150+ free educational sessions. Find solutions to tackle the toughest challenges—for life sciences & beyond—at North America’s largest packaging & processing event.